Company / Net Income
TherapeuticsMD, Inc. Net Income History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$10.3M
FY2024
5-year range
-$176.1M / $112.0M
FY2020-FY2024
Trend
-109.2%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Net Income has fluctuated over the past 10 years, ranging from -$176M in FY2021 to $112M in FY2023.
Based on SEC 10-K filings.
-$10M in FY2024.
Improved from -$172M to -$10M over the past 2 years.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, net income decreased 109.2% year-over-year.
- Peak net income was recorded in FY2023.
- Lowest net income in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.77 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$10.3M | -109.2% |
| FY2023 | $112.0M | +165.0% |
| FY2022 | -$172.4M | +2.1% |
| FY2021 | -$176.1M | -32.8% |
| FY2020 | -$132.6M | -72.4% |
| FY2019 | -$76.9M | +14.4% |
| FY2018 | -$89.9M | -5.6% |
| FY2017 | -$85.1M | -56.9% |
| FY2016 | -$54.2M | -90.8% |
| FY2015 | -$28.4M | +19.1% |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026